Navigating an Increasingly Competitive MASH Landscape
The MASH treatment landscape is evolving rapidly. With two FDA-approved therapies, expanding clinical programmes and multiple investigational mechanisms, pharmaceutical companies face increasing pressure to establish meaningful product differentiation.
Clinical efficacy alone may not define competitive advantage. Physician preferences, patient expectations, safety and tolerability, treatment convenience and payer requirements all influence the potential positioning of an emerging therapy.
This makes evidence-driven MASH Target Product Profile (TPP) development an important component of pharmaceutical research and development. Through structured MASH Market Research, pharmaceutical companies can better understand stakeholder expectations, evaluate unmet clinical needs and identify opportunities to strengthen the positioning of emerging therapies.
At SPER Market Research, we support pharmaceutical and biotechnology companies with specialised MASH Primary Market Research to develop, refine and validate differentiated MASH TPPs. Our research approach combines clinical evidence, physician perspectives and market insights to support informed product development decisions.
Our MASH TPP Research Solutions
We provide four integrated research solutions to support MASH TPP Development and commercial decision-making.
Unmet Need & Competitive Positioning
Understand clinical and commercial white spaces through specialist stakeholder research and MASH Competitive Landscape assessment.
- Hepatologist and endocrinologist interviews.
- Benchmarking against approved and emerging therapies.
- Assessment of unmet clinical needs.
- Identification of differentiation opportunities.
Deliverable: Unmet-need assessment and competitive positioning framework.
TPP Attribute Prioritisation
Identify which product attributes matter most to physicians, patients and other stakeholders to support effective Pharmaceutical TPP Development.
- Fibrosis improvement and MASH resolution.
- Weight-loss and metabolic benefits.
- Safety and tolerability.
- Dosing frequency and administration preferences.
- Conjoint Analysis and MaxDiff studies.
These methodologies help assess stakeholder preferences, evaluate attribute trade-offs and identify opportunities for meaningful MASH Product Differentiation.
Deliverable: Attribute importance scores, preference shares and trade-off maps.
Payer & Market Access Research
Understand reimbursement expectations and market-specific evidence requirements through structured MASH Market Access Research.
- Payer and HTA stakeholder interviews.
- Willingness-to-reimburse assessment.
- Comparative clinical value research.
- Market access and evidence requirement assessment.
Deliverable: Payer insights and market-specific access evidence.
Competitive Intelligence
Monitor the evolving MASH pipeline and assess opportunities for asset differentiation through comprehensive MASH Competitive Landscape research.
- Mechanism-of-action benchmarking.
- Clinical trial and milestone tracking.
- Efficacy and safety evidence assessment.
- Competitive positioning and KOL mapping.
Deliverable: MASH competitive landscape and asset differentiation reports.
Integrated Research Across the MASH Stakeholder Ecosystem
Our research framework brings together perspectives from multiple stakeholders to support MASH TPP research for pharmaceutical companies.
- Hepatologists: Clinical expectations and treatment preferences.
- Endocrinologists: Metabolic management and treatment selection.
- Primary Care Physicians: Patient identification and referral pathways.
- Payers and HTA Stakeholders: Reimbursement expectations and evidence requirements.
- Patients: Treatment preferences, convenience and treatment burden.
By integrating these perspectives, SPER helps clients understand the attributes that influence product evaluation and potential market acceptance. This stakeholder-led approach also strengthens the evidence base required for effective TPP development and product positioning.
From Unmet Need to a Stakeholder-Validated TPP
Our five-stage research framework supports the complete TPP development journey:
01 / Unmet Need
Identify clinical and commercial opportunities.
02 / Draft TPP
Define relevant product attributes and stakeholder expectations.
03 / Target TPP
Assess desired product performance and attribute trade-offs.
04 / Refine & Defend
Evaluate competitive differentiation and product positioning.
05 / Validated TPP
Consolidate stakeholder evidence to support development and commercial decisions.
Each stage can be commissioned independently or as part of a continuous research programme. Our approach to MASH TPP Development helps pharmaceutical and biotechnology companies align product attributes with clinical expectations, stakeholder preferences and evolving market requirements.
Research Methodologies and Execution
SPER integrates qualitative and quantitative methodologies to deliver actionable insights through Primary Market Research for MASH Therapies, including:
- In-depth interviews and focus groups.
- Conjoint Analysis and MaxDiff.
- CATI, CAPI and CAWI.
- Patient journey mapping.
- Decision modelling and MCDA.
- Digital and mobile research.
- Competitive intelligence and secondary research.
Our structured engagement process covers project scoping, respondent feasibility, research design, recruitment, fieldwork monitoring and quality-checked deliverables.
Typical engagement timelines are 4–10 weeks, depending on research scope, geography, sample requirements and respondent availability.
Partner with SPER Market Research
Whether you are evaluating an emerging MASH asset, developing an early-stage TPP, refining a Phase 2/3 product profile or assessing competitive differentiation, understanding stakeholder expectations is essential.
SPER Market Research helps translate primary research into actionable insights for pharmaceutical product development and commercial strategy. Our specialised MASH Market Research capabilities support informed decisions across unmet needs assessment, TPP attribute prioritisation, competitive intelligence and payer research.
Let's discuss your MASH TPP research requirements.
Explore MASH ResearchSPER Market Research – Primary Market Research. Strategic Decisions.
